Although prenatal care at our institution is free, adequacy was thought to be low. The main factors associated with poor prenatal care were mostly conditions related to poverty.

INTRODUCTION: Over 50% of pregnancies in the USA are unintended. Current contraception is very effective, if available and used correctly. We surmised the postpartum visit to be a key time to provide education and access to contraception. Thus we wanted to decrease our short interval pregnancy (less than 18 months, SIP) incidence as a simple measure of decreasing unintended pregnancies. METHODS: We retrospectively compared patients with SIP and those without with respect to age, race, parity, work status, attendance at postpartum visit (PPV), insurance status, breast feeding, and immediate postpartum medroxyprogesterone use. Modifiable risk factors would then be adjusted and the SIP incidence would be reassessed. RESULTS: We noted out of 991 deliveries that occurred from 5/2011 to 1/2013, 89 (8.9%) had an SIP. Only age (26.7 vs. 28.4 y, p=0.01) and PPV (40.9% vs. 67.4%, p=0.03) were significantly different in the SIP patients. Therefore, we changed our PPV timing from 6 weeks to 3 weeks in an effort to increase our PPV attendance. In the subsequent prospective time period from 1/2014 to 5/2016, we had 1021 births and 49 SIP births. Thus we had a decrease in our SIP from 8.9% to 4.8% (p=0.02) after changing the timing of our PPV. In addition, we increase our overall PPV attendance from 61% to 73% (p=0.04). CONCLUSION: Altering the timing of postpartum visit from 6 weeks to 3 weeks increased the frequency of attendance and may have decrease the unintended pregnancy rate.

females. Obstet Gynecol 2012;119:772-9.) of a single-dose emergency contraceptive demonstrated young women's ability to appropriately select and correctly use the emergency contraceptive. This post hoc analysis examined the safety of the emergency contraceptive in various age subgroups.

No abstract

climates and interaction with other Federal programs, including Title X and 340B drug pricing program add complexity to states' ability to pay and deliver LARC to women. Specific policies such as the promotion of postpartum LARC insertion have been embraced by most states (8 of 9 sampled). Other policy innovations such as pharmacy stocking have been pursued less frequently (2 of 9 states).CONCLUSION: Current Medicaid LARC policies are heterogeneous and complex, which may hinder development of effective promotion and use of LARC as first line contraceptives for women who desire them. Policy makers should focus on eligibility, payment mechanisms and well-coordinated delivery systems to achieve optimal family planning care.